urofollitropin


Also found in: Wikipedia.

urofollitropin

 [u″ro-fol´ĭ-tro″pin]
a preparation of gonadotropins from the urine of postmenopausal women; it contains follicle-stimulating hormone and is used in conjunction with human chorionic gonadotropin to induce ovulation in the treatment of female infertility and to stimulate multiple oocyte development in ovulatory patients utilizing assisted reproductive technologies. Administered by subcutaneous injection.

ur·o·fol·li·tro·pin

(yūr'ō-fol'i-trō'pin),
A preparation of gonadotropin extracted from the urine of postmenopausal women, used in conjunction with human chorionic gonadotropin to induce ovulation.
See also: menotropins.

urofollitropin

/uro·fol·li·tro·pin/ (-fol´ĭ-tro″pin) a preparation of gonadotropins from the urine of postmenopausal women, containing follicle-stimulating hormone and used in conjunction with human chorionic gonadotropin to induce ovulation.

urofollitropin

[u′rofol′itro′pin]
a preparation of gonadotropins from the urine of postmenopausal women. It contains follicle-stimulating hormone and is used in conjunction with human chorionic gonadotropin to induce ovulation in the treatment of female infertility and to stimulate multiple oocyte development in ovulatory patients using assisted reproductive technologies. Administered by subcutaneous injection.

Bravelle

A lyophilised formulation of follicle-stimulating hormone purified from the urine of postmenopausal women, which is used to induce ovulation and as part of the regimen for assisted reproductive technologies—e.g., in vitro fertilisation.

Contraindications Bravelle
• High FSH level indicating primary ovarian failure;
• Uncontrolled thyroid and adrenal dysfunction;
• An organic intracranial lesion—especially pituitary tumours;
• Any cause of infertility other than anovulation;
• Abnormal bleeding of undetermined origin;
• Ovarian cysts or enlargement not due to polycystic ovary syndrome;
• Prior hypersensitivity to urofollitropins, purified;
• Pregnancy.

u·ro·fol·li·tro·pin

(yūr'ō-fol'i-trō'pin)
A preparation of gonadotropin extracted from the urine of postmenopausal women, used in conjunction with human chorionic gonadotropin to induce ovulation.
See also: menotropins
References in periodicals archive ?
Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation.
BRAVELLE is contraindicated in women with a prior hypersensitivity to urofollitropins, purified.